Belgium

 

Amedes could sell fast

We hear talks to sell German/Belgian lab group amedes are far advanced, and not to private equity.

European healthcare property market grew by 33% in 2014

The European sale and leaseback healthcare property market grew by 33% in 2014, a new study by Your Care Consult reveals. We speak to Stéphane Pichon, managing director at Your Care, about the market and its prospects.

Belgian REIT Aedifica expands its German portfolio

Belgian REIT Aedifica has released its half-year results for 2014/2015. With 15 senior houses added since June 2014, the nursing home sector represents 70% of Aedifica’s portfolio. We speak to Stefaan Gielens, CEO of Aedifica, about the results and the company’s plans for the future.

REITs are sweet on healthcare

Real estate investment trusts (REITs) are switching their portfolios from office to healthcare commercial properties. Lease terms of 25-30 years and yields of roughly 6% are an attractive offering in a growing market. Underlying growth drivers in healthcare ensure long-term demand for Opco, mitigating risk for the Propco.

Report: Trends and innovations in the elderly care market in Europe

Elderly care groups are expanding into new business models such as the step down market, homecare and domiciliary care to met the needs of Europe’s fast growing elderly population. Here we talk to policymakers, CEOs and academics about innovations and outline the five main trends: the personalisation of care, changes in payers attitude, a shift to homecare, and the emergence of an Eastern European market.

Gilde raises €100m healthcare services fund

Dutch private equity specialist Gilde Healthcare has closed a new €100m healthcare services fund in just three months. We speak to Jasper van Gorp, managing partner at Gilde, about the fund.

Cerba buys Novescia

PAI-backed Franco-Belgian lab group Cerba is to buy Novescia, the national French lab chain for €275m. We reflect on the deal and the state of the lab market.

Interview: Bart Diels, Managing Partner, Head of Health & Care, Gimv

Listed investment company Gimv (Euronext: GIMB) is unusual in that it covers every aspect of health – biopharma, medtech and healthcare services – with a focus on mid-caps and a Pan-European approach. It is willing to invest as little as a few million euros up to € 50m and can hold a stake for up to 10-12 years. Active in biopharma since the early eighties, it has also made several investments in healthcare services and medical technologies. So how does Mr. Diels who has worked in VC and private equity for 20 years, view healthcare services as an investment perspective?

Belgian REIT Cofinimmo moves into Germany

Belgian REIT Cofinimmo recently announced its first healthcare acquisition in Germany, a Celenus-operated rehabilitation centre in Baden-Baden. Head of healthcare investments at Cofinimmo, Sebastien Berden, explains why Confinimmo plans to focus entirely on healthcare.

Find Us